Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

Joseph J. Busch, Jr., M.D. , a board-certified radiologist and Founder of the Busch Center in Alpharetta, GA, will give a presentation titled "Robotic Assisted MRI-Guided Transurethral Ultrasound ...

As cancer care becomes both more advanced and more specialized, options in rural areas have shrunk.

The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a ...

Filed Phase 3 Amendment Incorporates PFS as Interim Primary Endpoint Expected to Shorten Trial Duration and Reduce Costs. Conference Call and Webcast Today at 8:00 am Eastern Time ...

Bayer BAYRY announced that the European Commission ("EC") has approved a label expansion of Kerendia (finerenone) in the ...

Michele Seyranian, CEO of The Gathering Place, said the Beachwood-based nonprofit, which provides support groups, services ...

Researchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take ...

An updated edition of the February 5, 2026, article. The global oncology market is entering a period of rapid evolution, fueled by rising cancer incidence, aging populations and continued scientific ...

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

Filed Phase 3 Amendment Incorporates PFS as Interim Primary Endpoint Expected to Shorten Trial Duration and Reduce Costs Conference Call and Webcast Today at 8:00 am Eastern Time PRINCETON, N.J.